Free Trial

MarketBeat Instant News Alerts

Myriad Genetics logo with Medical background

Myriad Genetics (NASDAQ:MYGN) Downgraded to Equal Weight Rating by Wells Fargo & Company

MarketBeat

Wells Fargo & Company cut Myriad Genetics from an "overweight" rating to an "equal weight" rating and set a $6.00 price objective for the company. in a research report on Wednesday.

NASDAQ:MYGN
Read Myriad Genetics (NASDAQ:MYGN) Downgraded to Equal Weight Rating by Wells Fargo & Company
Sarepta Therapeutics logo with Medical background

Morgan Stanley Has Lowered Expectations for Sarepta Therapeutics (NASDAQ:SRPT) Stock Price

MarketBeat

Morgan Stanley decreased their target price on Sarepta Therapeutics from $182.00 to $113.00 and set an "overweight" rating for the company in a research report on Wednesday.

NASDAQ:SRPT
Read Morgan Stanley Has Lowered Expectations for Sarepta Therapeutics (NASDAQ:SRPT) Stock Price
Sarepta Therapeutics logo with Medical background

Sarepta Therapeutics (NASDAQ:SRPT) Given New $40.00 Price Target at HC Wainwright

MarketBeat

HC Wainwright reduced their price target on shares of Sarepta Therapeutics from $75.00 to $40.00 and set a "neutral" rating on the stock in a research note on Wednesday.

NASDAQ:SRPT
Read Sarepta Therapeutics (NASDAQ:SRPT) Given New $40.00 Price Target at HC Wainwright
Tempus AI logo with Medical background

Tempus AI's (TEM) Buy Rating Reaffirmed at Needham & Company LLC

MarketBeat

Needham & Company LLC reiterated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research note on Wednesday.

NASDAQ:TEM
Read Tempus AI's (TEM) Buy Rating Reaffirmed at Needham & Company LLC
Upstart logo with Finance background

Morgan Stanley Has Lowered Expectations for Upstart (NASDAQ:UPST) Stock Price

MarketBeat

Morgan Stanley dropped their price objective on shares of Upstart from $70.00 to $50.00 and set an "equal weight" rating on the stock in a research note on Wednesday.

NASDAQ:UPST
Read Morgan Stanley Has Lowered Expectations for Upstart (NASDAQ:UPST) Stock Price
Vanda Pharmaceuticals logo with Medical background

HC Wainwright Reaffirms "Buy" Rating for Vanda Pharmaceuticals (NASDAQ:VNDA)

MarketBeat

HC Wainwright reissued a "buy" rating and set a $20.00 target price on shares of Vanda Pharmaceuticals in a research note on Wednesday.

NASDAQ:VNDA
Read HC Wainwright Reaffirms "Buy" Rating for Vanda Pharmaceuticals (NASDAQ:VNDA)

Trending News

All MarketBeat Instant News Alerts

Viper Energy logo with Energy background

Viper Energy's (VNOM) "Outperform" Rating Reiterated at Evercore ISI

MarketBeat
NASDAQ:VNOM
Read Viper Energy's (VNOM) "Outperform" Rating Reiterated at Evercore ISI
Kitwave Group logo with Consumer Defensive background

Kitwave Group (LON:KITW) Earns Buy Rating from Canaccord Genuity Group

MarketBeat
LON:KITW
Read Kitwave Group (LON:KITW) Earns Buy Rating from Canaccord Genuity Group
Marvell Technology logo with Computer and Technology background

William Blair Issues Pessimistic Outlook for MRVL Earnings

MarketBeat
NASDAQ:MRVL
Read William Blair Issues Pessimistic Outlook for MRVL Earnings
Palantir Technologies logo with Business Services background

Wedbush Equities Analysts Boost Earnings Estimates for PLTR

MarketBeat
NASDAQ:PLTR
Read Wedbush Equities Analysts Boost Earnings Estimates for PLTR
ServiceNow logo with Computer and Technology background

William Blair Estimates ServiceNow's Q1 Earnings (NYSE:NOW)

MarketBeat
NYSE:NOW
Read William Blair Estimates ServiceNow's Q1 Earnings (NYSE:NOW)
Axsome Therapeutics logo with Medical background

Axsome Therapeutics (NASDAQ:AXSM) Price Target Lowered to $180.00 at HC Wainwright

MarketBeat
NASDAQ:AXSM
Read Axsome Therapeutics (NASDAQ:AXSM) Price Target Lowered to $180.00 at HC Wainwright
Tronox logo with Basic Materials background

BMO Capital Markets Reiterates Market Perform Rating for Tronox (NYSE:TROX)

MarketBeat
NYSE:TROX
Read BMO Capital Markets Reiterates Market Perform Rating for Tronox (NYSE:TROX)
Albertsons Companies logo with Consumer Staples background

Albertsons Companies (NYSE:ACI) Upgraded at BMO Capital Markets

MarketBeat
NYSE:ACI
Read Albertsons Companies (NYSE:ACI) Upgraded at BMO Capital Markets
Howard Hughes logo with Finance background

Howard Hughes (NYSE:HHH) Given New $80.00 Price Target at BMO Capital Markets

MarketBeat
NYSE:HHH
Read Howard Hughes (NYSE:HHH) Given New $80.00 Price Target at BMO Capital Markets
SolarEdge Technologies logo with Energy background

SolarEdge Technologies (NASDAQ:SEDG) Price Target Cut to $18.00 by Analysts at JPMorgan Chase & Co.

MarketBeat
NASDAQ:SEDG
Read SolarEdge Technologies (NASDAQ:SEDG) Price Target Cut to $18.00 by Analysts at JPMorgan Chase & Co.
Marriott International logo with Consumer Discretionary background

BMO Capital Markets Increases Marriott International (NASDAQ:MAR) Price Target to $265.00

MarketBeat
NASDAQ:MAR
Read BMO Capital Markets Increases Marriott International (NASDAQ:MAR) Price Target to $265.00
CRISPR Therapeutics logo with Medical background

Needham & Company LLC Lowers CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $81.00

MarketBeat
NASDAQ:CRSP
Read Needham & Company LLC Lowers CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $81.00
Corbus Pharmaceuticals logo with Medical background

Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target Cut to $40.00 by Analysts at HC Wainwright

MarketBeat
NASDAQ:CRBP
Read Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target Cut to $40.00 by Analysts at HC Wainwright
Arcos Dorados logo with Retail/Wholesale background

Arcos Dorados (ARCO) Projected to Post Quarterly Earnings on Wednesday

MarketBeat
NYSE:ARCO
Read Arcos Dorados (ARCO) Projected to Post Quarterly Earnings on Wednesday
DXC Technology logo with Computer and Technology background

DXC Technology (DXC) Projected to Post Earnings on Wednesday

MarketBeat
NYSE:DXC
Read DXC Technology (DXC) Projected to Post Earnings on Wednesday
FrontView REIT logo with Finance background

FrontView REIT (FVR) Projected to Post Earnings on Wednesday

MarketBeat
NYSE:FVR
Read FrontView REIT (FVR) Projected to Post Earnings on Wednesday
Vox Royalty logo with Basic Materials background

Vox Royalty (VOXR) Projected to Post Earnings on Wednesday

MarketBeat
NASDAQ:VOXR
Read Vox Royalty (VOXR) Projected to Post Earnings on Wednesday
2seventy bio logo with Medical background

2seventy bio (TSVT) Projected to Post Quarterly Earnings on Wednesday

MarketBeat
NASDAQ:TSVT
Read 2seventy bio (TSVT) Projected to Post Quarterly Earnings on Wednesday
Supernus Pharmaceuticals logo with Medical background

Supernus Pharmaceuticals (SUPN) to Release Quarterly Earnings on Wednesday

MarketBeat
NASDAQ:SUPN
Read Supernus Pharmaceuticals (SUPN) to Release Quarterly Earnings on Wednesday
Continental Aktiengesellschaft logo with Auto/Tires/Trucks background

Continental Aktiengesellschaft (CTTAY) to Release Quarterly Earnings on Wednesday

MarketBeat
OTCMKTS:CTTAY
Read Continental Aktiengesellschaft (CTTAY) to Release Quarterly Earnings on Wednesday
Pharvaris logo with Medical background

Pharvaris (PHVS) Projected to Post Earnings on Wednesday

MarketBeat
NASDAQ:PHVS
Read Pharvaris (PHVS) Projected to Post Earnings on Wednesday
DiaMedica Therapeutics logo with Medical background

DiaMedica Therapeutics (DMAC) Projected to Post Earnings on Wednesday

MarketBeat
NASDAQ:DMAC
Read DiaMedica Therapeutics (DMAC) Projected to Post Earnings on Wednesday
STERIS logo with Medical background

STERIS (STE) Projected to Post Earnings on Wednesday

MarketBeat
NYSE:STE
Read STERIS (STE) Projected to Post Earnings on Wednesday
Neonode logo with Computer and Technology background

Neonode (NEON) to Release Earnings on Wednesday

MarketBeat
NASDAQ:NEON
Read Neonode (NEON) to Release Earnings on Wednesday

Featured Articles and Offers

Sector News